e-ISSN: 2321-3647
logo

American Journal of Pharmacy and Health Research

Published

Analytical Method Development for simultaneous estimation of Calcipotriene and Dipropionate in Pharmaceutical dosage form.

Published in August 2017 Issue 8 (Vol. 5, Issue 8, 2017)

Analytical Method Development for simultaneous estimation of Calcipotriene and Dipropionate in Pharmaceutical dosage form. - Issue cover

Abstract

A new method was established simultaneous estimation of calcipotriene and dipropionate by RP-HPLC method. The chromatographic conditions were successfully developed for the separation of calcipotriene and dipropionate by using coloumn xterr C-18(4.6*250mm) 5µm, flow rate was 1.0ml/min mobile phase ratio Phosphate buffer (0.05M) pH 3.6: ACN (40:60%v/v) (pH was adjusted with ortho phosphoric acid), detection wave length 260nm.the instrument used was water HPLC auto sampler and PDA or detector. The analytical method was validated to ICH guidelines. The linearity range Dipropionate   and Calcipotriene were found to be from 100-500 µg/ml of Dipropionate and 1-5µg/ml of Calcipotriene. Linear regression coefficient was not more than 0.999.

Authors (3)

G. Sumalatha

SVS Group of Institutions, Sch...

View all publications →

L. Srikanth

SVS Group of Institutions, Sch...

View all publications →

A. Venkatesham

SVS Group of Institutions, Sch...

View all publications →

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Download Article

PDF

Best for printing and citation

File size: 0.0 MB
Format: PDF

Article Information

AJPHR508002

AJPHR-50-000002

2017-08-01

Article Impact

Views:1,379
Downloads:1,492

How to Cite

APA
MLA
Chicago
Harvard
Vancouver
IEEE
ACM
ACS
ABNT
Turabian
RIS (EndNote/Zotero/Mendeley)
BibTeX

Sumalatha & Srikanth & Venkatesham (2017). Analytical Method Development for simultaneous estimation of Calcipotriene and Dipropionate in Pharmaceutical dosage form.. American Journal of Pharmacy and Health Research, 5(8), xx-xx. https://ajphr.com/articles/AJPHR508002

Article Actions